# § 721.1760   Substituted benzotriazole derivatives.

(a) *Chemical substances and significant new uses subject to reporting.* (1) The chemical substances identified generically as substituted benzotriazole derivatives (PMNs P-93-374 and P-93-375) are subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. 


(2) The significant new uses are:


(i) *Protection in the workplace.* Requirements as specified in § 721.63 (a)(1), (b) (concentration set at 1.0 percent), and (c). 


(ii) *Hazard communication program.* Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(1)(i), (g)(1)(iv), (g)(1)(vi), (g)(2)(i), (g)(2)(v), and (g)(5).


(iii) *Industrial, commercial, and consumer activities.* Requirements as specified in § 721.80 (g), (v)(1), (w)(1), and (x)(1). 


(iv) *Release to water.* Requirements as specified in § 721.90 (a)(1), (b)(1), and (c)(1).


(b) *Specific requirements.* The provisions of subpart A of this part apply to this section except as modified by this paragraph.


(1) *Recordkeeping requirements.* Recordkeeping requirements specified in § 721.125 (a), (b), (c), (d), (f), (g), (h), (i), and (k) are applicable to manufacturers, importers, and processors of these substances.


(2) *Limitations or revocation of certain notification requirements.* The provisions of § 721.185 apply to this section. 



---

[N] [60 FR 11041, Mar. 1, 1995]




